Sometimes it’s hard to estimate the impact of shifting healthcare policies until providers actually begin putting them into practice. That seems to be the case with two significant shifts in federal policy that are now working their way toward implementation in clinical laboratories throughout the United States.
Sometimes called the “sunshine vitamin,” vitamin D is active in tissues and cells throughout the body, and is believed to help prevent or reduce a wide range of diseases. But researchers aren’t exactly sure what roles vitamin D plays, and judging how much vitamin D is enough—and for whom—remains something of a moving target.
So far as the realm of molecular diagnostics is concerned, 2013 may go into the books as a year of some significance. But further developments in the coming year could ultimately turn out to be even more important.
Some take-away from the annual conference from one of the presenters.
Regarding the Centers for Medicare and Medicaid Services’ long-awaited gap-fill recommendations for the molecular pathology codes—well, the agency released the national limitation amounts, but for only half of the molecular codes.
We begin a discussion in the pub(lication), to be continued in real time.
Staying purposefully in touch.
Vendors at the Clinical Lab Expo showcased products and services to help labs boost their output and operate in accordance with lean initiatives, with the ultimate goal of improving patient outcomes.
Gearing up for the 2013 AACC annual meeting and expo.
Robust discussion follows disclosure of an attempt to foil cancer.